Delivery Order SPE2DB22D1106-SPE2DB25FEZU8
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gentamicin 800 mg/20 mL vials totaling $1,791.07. This is a firm fixed-price delivery order under a non-competitive award with an ultimate completion date of September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued as a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,704.79 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gentamicin 800 mg/20 mL vials. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a competitively awarded, non-set-aside procurement action. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,414.01 by the Defense Logistics Agency's Medical Supply Chain for the supply of Gentamicin 800 mg/20 mL vials. The contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This...
- The Defense Logistics Agency awarded a $10,558.45 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gentamicin pediatric 20 mg/2 mL vials. This firm fixed-price contract, with an ultimate completion date of August 22, 2025, represents a competitively awarded (non-set-aside) procurement through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $163,801.69 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, competitively awarded contract (no set-aside) is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,791.72 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion on August 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $54,074.37 to AmerisourceBergen Drug Corp on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $85,972.33 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,192.65 to AmerisourceBergen Drug Corp on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZU8Delivery Order
The Defense Logistics Agency awarded a $2,287.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Gentamicin 800 mg/20 mL vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through its extensive federal contract portfolio with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical supplies, including generic and brand-name medications, across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent IDC vehicle enables flexible procurement of pharmaceutical commodities needed to support military healthcare programs worldwide and demonstrates the contractor's capability to meet federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/25/25 |